Stillbirth research projects
In the UK, 1 in every 250 pregnancies end in stillbirth – when a baby dies after 24 weeks gestation. This is equivalent to around 2,950 babies dying every year. Our research is helping to change this. Discover our stillbirth research projects here.
Stillbirth research
Bile acid levels increases the risk of poor outcomes of pregnancies with intrahepatic cholestasis of pregnancy (ICP)
Researchers have looked at information from 5,500 women with ICP, finding that the babies of women with high bile acid levels are most at risk of stillbirth.
Stillbirth research
Can steroid injections improve blood flow to babies at risk of stillbirth?
Finding out whether steroids can improve the blood flow through the placenta
Stillbirth research
Preventing stillbirth: the role of the immune system in rejecting the placenta
Tommy’s are studying chronic histiocytic intervillositis, which causes the immune system to reject the placenta, leading to stillbirth or miscarriage.
Stillbirth research
The role of placental blood vessels in growth restriction and stillbirth
Tommy's wants to find out why the placentas from babies who grow slowly have a smaller network of blood vessels than healthy placentas.
Stillbirth research
Is there a better way to test new treatments that could improve how well the placenta is working?
Tommy's researchers are working out the best way to test new therapies that could improve how well the placenta is functioning and so prevent stillbirth.
Stillbirth research
The effects of age on stillbirth
Our researchers want to find out more about why the placentas of older women do not work as well as they should so that we can develop new treatments to help prevent stillbirth.
Stillbirth research
The Tommy’s Project: understanding how pregnancy goes wrong
Our researchers are collecting information and tissue samples from thousands of women to better understand the causes of complications that can lead to stillbirth or neonatal death.
Stillbirth research
The INVEST study: Can increased fetal movement be a sign that something is wrong?
Tommy's researchers found no link between a baby moving more than normal for a period of time and worse pregnancy outcomes, including stillbirth.
Stillbirth research
The role of glutamine and glutamate in fetal growth restriction
Tommy's want to find out whether we can improve the way some placentas transfer amino acids glutamine and glutamate to babies to help them grow properly.
Stillbirth research
Bile acid levels increases the risk of poor outcomes of pregnancies with intrahepatic cholestasis of pregnancy (ICP)
Researchers have looked at information from 5,500 women with ICP, finding that the babies of women with high bile acid levels are most at risk of stillbirth.
Stillbirth research
Is there a better way to test new treatments that could improve how well the placenta is working?
Tommy's researchers are working out the best way to test new therapies that could improve how well the placenta is functioning and so prevent stillbirth.
Stillbirth research
The Tommy’s Project: understanding how pregnancy goes wrong
Our researchers are collecting information and tissue samples from thousands of women to better understand the causes of complications that can lead to stillbirth or neonatal death.
Stillbirth research
Can steroid injections improve blood flow to babies at risk of stillbirth?
Finding out whether steroids can improve the blood flow through the placenta
Stillbirth research
The role of placental blood vessels in growth restriction and stillbirth
Tommy's wants to find out why the placentas from babies who grow slowly have a smaller network of blood vessels than healthy placentas.
Stillbirth research
The INVEST study: Can increased fetal movement be a sign that something is wrong?
Tommy's researchers found no link between a baby moving more than normal for a period of time and worse pregnancy outcomes, including stillbirth.
Stillbirth research
Preventing stillbirth: the role of the immune system in rejecting the placenta
Tommy’s are studying chronic histiocytic intervillositis, which causes the immune system to reject the placenta, leading to stillbirth or miscarriage.
Stillbirth research
The effects of age on stillbirth
Our researchers want to find out more about why the placentas of older women do not work as well as they should so that we can develop new treatments to help prevent stillbirth.
Stillbirth research
The role of glutamine and glutamate in fetal growth restriction
Tommy's want to find out whether we can improve the way some placentas transfer amino acids glutamine and glutamate to babies to help them grow properly.